Early aspirin use may lower mortality risk in adults hospitalized with COVID-19

Among patients hospitalized with moderate COVID-19, those who received aspirin on the first day of hospitalization had a significantly lower risk for 28-day mortality than those who did not, according to a recent observational cohort study.
The findings are consistent with previous observational studies, Jonathan H. Chow, MD, an associate professor in the department of anesthesiology and critical care medicine at George Washington University School of Medicine and Health Sciences, and colleagues wrote in JAMA Network Open.
“This is our third study and the culmination of 15 months of work

Among patients hospitalized with moderate COVID-19, those who received aspirin on the first day of hospitalization had a significantly lower risk for 28-day mortality than those who did not, according to a recent observational cohort study.
The findings are consistent with previous observational studies, Jonathan H. Chow, MD, an associate professor in the department of anesthesiology and critical care medicine at George Washington University School of Medicine and Health Sciences, and colleagues wrote in JAMA Network Open.
“This is our third study and the culmination of 15 months of work